EDITORIAL
Published on 06 Sep 2021
Editorial: CD4+ T Cells in Cancer Immunotherapies
doi 10.3389/fimmu.2021.737615
- 2,183 views
- 5 citations
- Frontiers in Immunology
- T Cell Biology
- Research Topics
- CD4+ T Cells in Cancer Immunotherapies
CD4+ T Cells in Cancer Immunotherapies
25k
Total downloads
89k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 05 Jul 2021
A Biological Circuit Involving Mef2c, Mef2d, and Hdac9 Controls the Immunosuppressive Functions of CD4+Foxp3+ T-Regulatory Cells
doi 10.3389/fimmu.2021.703632
- 4,983 views
- 8 citations
REVIEW
Published on 28 Jun 2021
Epigenetic Reprogramming of CD4+ Helper T Cells as a Strategy to Improve Anticancer Immunotherapy
doi 10.3389/fimmu.2021.669992
- 5,646 views
- 27 citations
REVIEW
Published on 03 May 2021
Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy
doi 10.3389/fimmu.2021.669474
- 22,840 views
- 201 citations
REVIEW
Published on 12 Mar 2021
The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy
doi 10.3389/fimmu.2021.625667
- 14,014 views
- 68 citations
REVIEW
Published on 26 Feb 2021
The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies
doi 10.3389/fimmu.2021.625783
- 6,822 views
- 56 citations
REVIEW
Published on 23 Feb 2021
PSGL-1 Immune Checkpoint Inhibition for CD4+ T Cell Cancer Immunotherapy
doi 10.3389/fimmu.2021.636238
- 12,872 views
- 36 citations
REVIEW
Published on 30 Nov 2020
Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy
doi 10.3389/fimmu.2020.586907
- 8,561 views
- 56 citations
